December 20, 2007
KYTHERA Biopharmaceuticals Announces Discontinuation Of Actinic Keratosis Clinical Program
November 29, 2007
KYTHERA Biopharmaceuticals Appoints Amgen Veteran As Chief Financial Officer
November 14, 2007
KYTHERA Biopharmaceuticals Appoints Industry Veteran As Vice President, Regulatory Affairs
August 28, 2007
KYTHERA Biopharmaceuticals Initiates Phase II Study Of Its Adipolytic Agent For Reduction Of Submental Fat
April 24, 2007
KYTHERA Biopharmaceuticals Appoints Vice President, Product Development And Operations
April 24, 2007
KYTHERA Biopharmaceuticals Appoints New Chief Medical Officer
January 8, 2007
KYTHERA Biopharmaceuticals Signs Agreement For Access To Worldwide Rights For Topical Agent For The Treatment Of Actinic Keratos